Keyphrases
ST-elevation Myocardial Infarction (STEMI)
93%
Peru
82%
Peruvian
80%
Cardiogenic Shock
48%
Reperfusion
34%
Heart Failure
32%
Myocardial Infarction
27%
Acute Coronary Syndrome
27%
Percutaneous Coronary Intervention
25%
Fibrinolysis
21%
In-hospital Mortality
19%
Shock
18%
Hazard Ratio
18%
Hospitalization
17%
High Altitude
16%
Successful Reperfusion
15%
High Mortality
15%
Reperfusion Therapy
15%
In-hospital Adverse Outcomes
15%
Latin American
15%
Epidemiological Characteristics
14%
Acute ST-segment Elevation Myocardial Infarction
12%
Acute Myocardial Infarction
12%
Modified HEART Score
12%
Acute Decompensated Heart Failure
12%
Thoracic Pain
12%
No-reflow
12%
American Hospital
12%
Current Feature
12%
European Hospital
12%
Treatment Use
12%
1-year Survival
12%
Coronary Ectasia
12%
Clinical Variables
12%
Initial Management
12%
Mortality Factors
12%
Framingham
12%
Chronic Exposure
12%
Cardiovascular Events
12%
Framingham Risk Score
12%
Adult Population
12%
COVID-19 Pandemic Impact
12%
International Registry
12%
Latin Language
12%
Latin America (LATAM)
12%
Hemopericardium
12%
Pharmaco-invasive Strategy
12%
Confidence Interval
11%
Lima
11%
Adverse Events
10%
Medicine and Dentistry
ST Segment Elevation Myocardial Infarction
50%
Cardiogenic Shock
40%
Myocardial Infarction
32%
Congestive Heart Failure
30%
Acute Coronary Syndrome
28%
Adverse Event
21%
Cardiovascular System
21%
Shock (Circulatory)
18%
Hospital Mortality
18%
Fibrinolysis
14%
Infarction
13%
Percutaneous Coronary Intervention
12%
Acute Heart Infarction
12%
Thorax Pain
12%
Long Term Exposure
12%
Ectasia
12%
COVID-19
12%
Hemopericardium
12%
Primary Percutaneous Coronary Intervention
12%
Intra-Aortic Balloon Pump
8%
Angioplasty
7%
ST Elevation
7%
Health System
6%
Nutrition Monitoring
6%
Revascularization
6%
Ischemia
5%
Reperfusion Therapy
5%
Pharmacology, Toxicology and Pharmaceutical Science
ST Segment Elevation Myocardial Infarction
100%
Cardiogenic Shock
44%
Congestive Heart Failure
42%
Heart Infarction
34%
Acute Coronary Syndrome
25%
Hospital Mortality
23%
Infarction
20%
Acute Heart Infarction
16%
Adverse Event
15%
Long Term Exposure
12%
Cohort Study
8%
Cardiovascular Mortality
7%
Disease
7%
Heart Muscle Ischemia
6%
Ischemia
5%
All Cause Mortality
5%
Cerebrovascular Accident
5%
Cardiovascular Disease
5%
Bleeding
5%